EGM
AGIO icon

Engineers Gate Manager’s Agios Pharmaceuticals AGIO Stock Holding History

Engineers Gate Manager’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2M Buy
53,912
+24,992
+86% +$758K 0.03% 683
2026
Q1 		$978K Sell
28,920
-20,208
-41% -$573K 0.01% 1066
2025
Q4 		$1.34M Buy
+49,128
New +$1.72M 0.02% 892
2025
Q3 		– Sell
-16,548
Closed -$550K – 2125
2025
Q2 		$550K Sell
16,548
-6,169
-27% -$187K 0.01% 1432
2025
Q1 		$666K Sell
22,717
-37,488
-62% -$1.24M 0.01% 1299
2024
Q4 		$1.98M Buy
60,205
+36,192
+151% +$1.7M 0.03% 632
2024
Q3 		$1.07M Sell
24,013
-1,793
-7% -$81.4K 0.02% 950
2024
Q2 		$1.11M Sell
25,806
-10,764
-29% -$388K 0.03% 831
2024
Q1 		$1.07M Buy
36,570
+11,984
+49% +$321K 0.03% 792
2023
Q4 		$548K Buy
+24,586
New +$551K 0.02% 1127
2021
Q3 		– Sell
-16,603
Closed -$915K – 1601
2021
Q2 		$915K Sell
16,603
-231
-1% -$12.9K 0.06% 478
2021
Q1 		$869K Buy
16,834
+9,934
+144% +$492K 0.04% 651
2020
Q4 		$299K Sell
6,900
-9,198
-57% -$364K 0.01% 1296
2020
Q3 		$563K Buy
16,098
+10,886
+209% +$477K 0.03% 928
2020
Q2 		$279K Buy
+5,212
New +$241K 0.01% 1252
2020
Q1 		– Sell
-18,180
Closed -$868K – 1532
2019
Q4 		$868K Buy
18,180
+3,931
+28% +$149K 0.04% 716
2019
Q3 		$462K Buy
+14,249
New +$590K 0.02% 820
2019
Q2 		– Sell
-4,100
Closed -$277K – 1109
2019
Q1 		$277K Buy
+4,100
New +$239K 0.02% 756

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Engineers Gate Manager's AGIO Position: Q2 2026 in Review

Engineers Gate Manager increased its Agios Pharmaceuticals (AGIO) stake by 86% in Q2 2026, buying an estimated $758K and bringing the position to 53,912 shares worth $2M. The position accounts for 0.03% of the portfolio, ranked #683.

Engineers Gate Manager first reported a position in AGIO in Q1 2019 and has held it in 18 quarters since. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Engineers Gate Manager held 53,912 shares of Agios Pharmaceuticals worth $2M as of Q2 2026.
  • Engineers Gate Manager bought 24,992 Agios Pharmaceuticals shares in Q2 2026, an estimated $758K.
  • Agios Pharmaceuticals made up 0.03% of Engineers Gate Manager's portfolio in Q2 2026, its #683 holding.
  • Engineers Gate Manager first reported a position in Agios Pharmaceuticals in Q1 2019 and has held it in 18 quarters since.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.